VERICEL CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 47.86 USD | -0.76% |
|
-7.01% | +34.57% |
| 21/05 | Vericel Insider Sold Shares Worth $499,900, According to a Recent SEC Filing | MT |
| 08/05 | Vericel Q1 Loss Narrows, Revenue Increases; 2024 Outlook Lifted -- Shares Rise Pre-Bell | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VERICEL CORPORATION | Biopharmaceuticals | -0.79% | -7.01% | +34.57% | +45.48% | +193.99% | 234.41Cr |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- VCEL Stock
- Charts Vericel Corporation
- Comparison Chart
